eF-site ID 3pp1-A
PDB Code 3pp1
Chain A

click to enlarge
Title Crystal Structure of the Human Mitogen-activated protein kinase kinase 1 (MEK 1) in complex with ligand and MgATP
Classification TRANSFERASE/TRANSFERASE INHIBITOR
Compound Dual specificity mitogen-activated protein kinase kinase 1
Source Homo sapiens (Human) (MP2K1_HUMAN)
Sequence A:  MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH
LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS
ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL
REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA
NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR
YPIPPPDAKELELMFPMAIFELLDYIVNEPPPKLPSGVFS
LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDF
AGWLCSTIGLN
Description


Functional site

1) chain A
residue 77
type
sequence G
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

2) chain A
residue 78
type
sequence N
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

3) chain A
residue 80
type
sequence G
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

4) chain A
residue 95
type
sequence A
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

5) chain A
residue 97
type
sequence K
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

6) chain A
residue 143
type
sequence M
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

7) chain A
residue 144
type
sequence E
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

8) chain A
residue 146
type
sequence M
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

9) chain A
residue 150
type
sequence S
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

10) chain A
residue 153
type
sequence Q
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

11) chain A
residue 192
type
sequence K
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

12) chain A
residue 194
type
sequence S
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

13) chain A
residue 195
type
sequence N
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

14) chain A
residue 197
type
sequence L
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

15) chain A
residue 208
type
sequence D
description BINDING SITE FOR RESIDUE ATP A 400
source : AC1

16) chain A
residue 195
type
sequence N
description BINDING SITE FOR RESIDUE MG A 410
source : AC2

17) chain A
residue 208
type
sequence D
description BINDING SITE FOR RESIDUE MG A 410
source : AC2

18) chain A
residue 78
type
sequence N
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

19) chain A
residue 80
type
sequence G
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

20) chain A
residue 97
type
sequence K
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

21) chain A
residue 115
type
sequence L
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

22) chain A
residue 127
type
sequence V
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

23) chain A
residue 141
type
sequence I
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

24) chain A
residue 143
type
sequence M
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

25) chain A
residue 208
type
sequence D
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

26) chain A
residue 209
type
sequence F
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

27) chain A
residue 210
type
sequence G
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

28) chain A
residue 211
type
sequence V
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

29) chain A
residue 212
type
sequence S
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

30) chain A
residue 215
type
sequence L
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

31) chain A
residue 216
type
sequence I
description BINDING SITE FOR RESIDUE IZG A 500
source : AC3

32) chain A
residue 62
type
sequence E
description BINDING SITE FOR RESIDUE ACT A 590
source : AC4

33) chain A
residue 63
type
sequence L
description BINDING SITE FOR RESIDUE ACT A 590
source : AC4

34) chain A
residue 116
type
sequence Q
description BINDING SITE FOR RESIDUE ACT A 590
source : AC4

35) chain A
residue 131
type
sequence G
description BINDING SITE FOR RESIDUE ACT A 590
source : AC4

36) chain A
residue 132
type
sequence A
description BINDING SITE FOR RESIDUE ACT A 590
source : AC4

37) chain A
residue 144
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:19161339, ECO:0007744|PDB:3EQF
source Swiss-Prot : SWS_FT_FI4

38) chain A
residue 194
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:19161339, ECO:0007744|PDB:3EQF
source Swiss-Prot : SWS_FT_FI4

39) chain A
residue 74-97
type prosite
sequence LGAGNGGVVFKVSHKPSGLVMARK
description PROTEIN_KINASE_ATP Protein kinases ATP-binding region signature. LGAGNGGVVFkVshkpsglv..........MARK
source prosite : PS00107

40) chain A
residue 186-198
type prosite
sequence IMHRDVKPSNILV
description PROTEIN_KINASE_ST Serine/Threonine protein kinases active-site signature. ImHrDVKpsNILV
source prosite : PS00108

41) chain A
residue 74
type BINDING
sequence L
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613
source Swiss-Prot : SWS_FT_FI2

42) chain A
residue 143
type BINDING
sequence M
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613
source Swiss-Prot : SWS_FT_FI2

43) chain A
residue 150
type BINDING
sequence S
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613
source Swiss-Prot : SWS_FT_FI2

44) chain A
residue 192
type BINDING
sequence K
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613
source Swiss-Prot : SWS_FT_FI2

45) chain A
residue 208
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613
source Swiss-Prot : SWS_FT_FI2

46) chain A
residue 97
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:19161339, ECO:0007744|PDB:3EQH
source Swiss-Prot : SWS_FT_FI3

47) chain A
residue 218
type MOD_RES
sequence S
description Phosphoserine; by BRAF and RAF1 => ECO:0000269|PubMed:10409742, ECO:0000269|PubMed:20956560, ECO:0000269|PubMed:29433126, ECO:0000269|PubMed:8131746
source Swiss-Prot : SWS_FT_FI5

48) chain A
residue 222
type MOD_RES
sequence S
description Phosphoserine; by BRAF and RAF1 => ECO:0000269|PubMed:20956560, ECO:0000269|PubMed:29433126, ECO:0000269|PubMed:8131746
source Swiss-Prot : SWS_FT_FI6

49) chain A
residue 190
type ACT_SITE
sequence D
description Proton acceptor => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027
source Swiss-Prot : SWS_FT_FI1


Display surface

Download
Links